About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials in Los Angeles | 36 Studies

Clinical Trials HIV/AIDSLos Angeles

HIV/AIDS Clinical Trials in Los Angeles

Find 36 clinical trials for hiv/aids near Los Angeles, California. Connect with research centers in your area.

All HIV/AIDS trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-36 of 36 trials

CompletedThe Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate SymptomsTo determine the safety and usefulness of zidovudine (AZT) for the treatment of children 3 months to 12 years of age.NCT00000990·Downey, California and 32 others

HIV/AIDS Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedCSP #512 - Options in Management With Anti-RetroviralsThis 'pragmatic' trial is a 2X2 open randomized study of patients in advanced HIV disease who have failed on conventional Highly Active Antiretroviral Therapy (HAART) regimens…NCT00050089·Phoenix, Arizona and 29 others

CompletedImmunologic Memory (Supp. of ATN 024)This is an exploratory, laboratory-based evaluation of cellular immune response to immunization with hepatitis B surface antigen in HIV-infected and HIV-uninfected adolescents.NCT00142753·Los Angeles, California and 3 others

CompletedA Study of HIV and Cytomegalovirus (CMV) in HIV-Infected PatientsTo define relationships between 1) HIV load and risk of CMV disease, 2) CMV load and the risk of developing CMV disease, and 3) CMV load and HIV load.NCT00001089·Birmingham, Alabama and 35 others

CompletedA Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineTo evaluate the safety and tolerance of atovaquone (566C80) in AIDS patients with central nervous system (CNS) toxoplasmosis.NCT00001994·Los Angeles, California and 21 others

CompletedSafety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and AdolescentsThe purpose of this study is to compare two flu vaccines to determine their safety and ability to stimulate an immune response in HIV infected children and adolescents.NCT00091702·Birmingham, Alabama and 60 others

CompletedSafety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and AdolescentsIntegrase is 1 of 3 HIV (Human Immunodeficiency Virus)-1 enzymes required for viral replication. Raltegravir is a drug that prevents integrase from working properly.NCT00485264·Alhambra, California and 41 others

CompletedVaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With MalesRATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to prevent viral infection.NCT01209325·La Jolla, California and 18 others

CompletedThe Safety of Different Dose Levels of Zidovudine in HIV-Infected ChildrenTo evaluate and compare differences in tolerance and side effects associated with two different dosages of zidovudine (AZT) when used to treat children with HIV infection.NCT00000983·Downey, California and 50 others

CompletedComparison of Three Hepatitis B Vaccination Regimens in HIV-Positive YouthHepatitis B is a contagious virus that can damage a person's liver.NCT00106964·Los Angeles, California and 10 others

CompletedSafety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected ChildrenThe purpose of this study is to determine the safety of and immune response to a new human papillomavirus (HPV) vaccine in HIV (Human immunodeficiency virus) infected children…NCT00339040·Alhambra, California and 33 others

CompletedStudy to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsTo evaluate the safety and efficacy of Stribild®, a single tablet regimen (STR) containing fixed doses of elvitegravir (EVG)/cobicistat (COBI \[GS-9350\])/emtricitabine…NCT01106586·Phoenix, Arizona and 145 others

CompletedPrevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV InfectionThis is a strategic prospective cohort study which will measure the effects of early intensive antiretroviral therapy (ART) on the establishment and persistence of HIV-1…NCT03205696·Los Angeles, California and 2 others

Not yet recruitingEvaluating a Clinical Decision Support Tool for Antiretroviral Therapy OptimizationThis study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients.NCT07219862·Los Angeles, California

CompletedPhase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive WomenOBJECTIVES: I.NCT00004400·Los Angeles, California and 2 others

CompletedImpact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young WomenThe purpose of this study is to evaluate the immunogenicity, safety, tolerability, and behavioral impact of an HPV-6, -11, -16, -18 vaccine in HIV-infected young women.NCT00710593·Los Angeles, California and 13 others

PreviousPage 2 of 2

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia